Clinical Trials Browser

NIH × Interventional × volociximab × Clear all

NCT00278187 2013-12-19

Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms